National Institute of Allergy and Infectious Diseases
  National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Labs at NIAID
 Info about NIAID Labs
  Comparative Medicine
  Cytokine Biology
  LAD
  LCID
  LCMI
  LHD
  LHBP
  LIG
  LI
  LIP
  LID
  LIR
  LICP
  MVDB
  LMVR
  LMI
  LMM
  LPD
   Office of the Chief
   Cell Biology
   Gastrointestinal Parasites
   Helminth Immunology
   Immunopatho-genesis
   Immunobiology
   Intracellular Parasite Biology
   Molecular Parasitology
   Mucosal Immunology
  LPVD
  LV
  LVD
  LZP
  PSIIM
  Research Technologies
  Vaccine Research Center
 Find Key Lab Scientists
 Training in NIAID Labs


Laboratory of Parasitic Diseases

Molecular Parasitology Unit

Michael E. Grigg, Ph.D.

Investigator

Chief, Molecular Parasitology Unit

Description of Research Program

Parasitic protozoa are serious pathogens of humans and animals throughout the world whose biology is quite remarkable. Studies investigating their cell and molecular biology have identified unique paradigms of eukaryotic pathogenesis, including antigenic variation, virulence shifts and RNA editing. The primary goal of the Molecular Parasitology Unit is to understand the molecular basis of virulence and pathogenesis in a class of parasitic protozoa known as the Apicomplexa.

Our research is focused primarily on the food and water-borne parasite, Toxoplasma gondii, a serious pathogen capable of causing lethal infections in the developing fetus and in immunocompromised patients, as well as blinding chorioretinitis in both children and adults. In all hosts, Toxoplasma establishes long-term chronic infections that persist for life despite the induction of strong immunity. Eliminating the ability of the parasite to evade sterilizing immunity is central to controlling both its propagation and pathogenesis, as no vaccine or drug is currently capable of doing this. And despite its prevalence and importance as a human pathogen, surprisingly little is known about how Toxoplasma causes disease.

Our three-pronged research approach involves: (1) investigating the genetic basis of virulence shifts caused via sexual recombination in parasitic protozoa using Toxoplasma gondii as the genetic model; (2) determining the molecular interactions that control Toxoplasma pathogenesis in a naturally infectious, murine disease model; and (3) utilizing genomic and genetic tools to identify virulence factors essential for the ecological success of Apicomplexan pathogens from both a population and evolutionary vantage.

To conduct this research, our laboratory has developed a combination of new genetic, genomic, and molecular imaging techniques to identify parasite genes essential for entry into host cells, colonization, and subversion of host immunity in animal models of natural infection.

Current projects include the following:

  • Investigating Toxoplasma outbreaks associated with unusually severe clinical disease to assess the contribution of sexual meioses in the evolution of new strains that possess altered biological potential
  • Functional genomic, genetic, and bioinformatic approaches to identify and characterize discrete virulence factors that contribute to disease pathogenesis
  • Bioimaging the host-pathogen interaction in vivo using real-time molecular imaging and in situ within anatomically intact host tissues to visualize host immune cells responding to parasite infected targets
  • Gene expression, structural, and immunological analyses of parasite cell-surface antigens that regulate host immunity and contribute to parasite infectivity

Since relatively little is known about eukaryotic pathogenic processes as compared to the field of bacterial or viral pathogenesis, it is likely that entirely new mechanisms and principles of pathogenesis will emerge from our work.

Selected Recent Publications

(View list in PubMed.)

M.E. Grigg. Population genetics, sex and the emergence of clonal lines of Toxoplasma gondii. In: “The Biology of Toxoplasma gondii” Ed. D. Soldati & J.W. Ajioka. 2007. Horizon Press

P.A. Conrad, M. Miller, C. Kreuder, E.R. James, J. Mazet, H. Dabritz, D.A. Jessup and M.E. Grigg. Sea otters as sentinels of Toxplasma gondii flow into the marine environment. Intl. J. Parasitol. 2005. 35:1155-68.

C.G. Jung*, C.Y-F. Lee*, and M.E. Grigg. The SRS superfamily of Toxoplasma gondii surface proteins. Intl. J. Parasitol. 2004. 34:285-296. *joint first-authors.

M.E. Grigg*, J-T. Kong*, L. Uyetake, S. Parmley and J.C. Boothroyd. Serotyping of Toxoplasma gondii infections in humans using synthetic peptides. J. Infect. Dis. 2003. 187:1484-1495.*joint first-authors

X-L. He, M.E. Grigg, J.C. Boothroyd, and K.C. Garcia. Structure of the immunodominant surface antigen from the Toxoplasma gondii SRS superfamily. Nature Struct. Biol. 2002. 9:606-611.

M.E. Grigg, S. Bonnefoy, A.B. Hehl, Y. Suzuki, and J.C. Boothroyd. Success and virulence in Toxoplasma as the result of sexual recombination between two distinct ancestries. Science 2001. 294:161-165.

    Michael E. Grigg, Ph.D. image

    Contact Info

    Michael E. Grigg, Ph.D. Phone: 301-402-1609
    Fax: 301-402-0079
    E-mail: griggm@niaid.nih.gov
    Mail:
    Bldg 4, Rm B1-06
    4 Center Drive, MSC 0425
    Bethesda, MD 20892-0425


    See Also

     Division of Intramural Research (DIR)

    Search in Labs at NIAID
     
    E-mail Icon E-mail this page
    Print Icon Print this page
    Plug-ins and Viewers
    To open PDFs on this page, download and install the Adobe Acrobat Reader.
    Michael E. Grigg, Ph.D. image

    Contact Info

    Michael E. Grigg, Ph.D. Phone: 301-402-1609
    Fax: 301-402-0079
    E-mail: griggm@niaid.nih.gov
    Mail:
    Bldg 4, Rm B1-06
    4 Center Drive, MSC 0425
    Bethesda, MD 20892-0425


    See Also

     Division of Intramural Research (DIR)